Michael Khan
Director Ejecutivo en Argonaute RNA Ltd. .
Origen de la red de primer grado Michael Khan.
Entidad | Tipo de entidad | Industria | |
---|---|---|---|
Public Company | Miscellaneous Commercial Services | 14 | |
Diabetes UK
3
| Non-Profit Organization | 3 | |
Argonaute RNA Ltd.
Argonaute RNA Ltd. Miscellaneous Commercial ServicesCommercial Services Argonaute RNA Ltd. develops safe and reliable methods of temporarily silencing target genes in different tissue cells. The company is based in Bristol, UK. Michael Khan has been the CEO of the British company since 2021.
1
| Holding Company | Miscellaneous Commercial Services | 1 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Michael Khan a través de su red personal
Empresa | Sector | Personas relacionadas | Puesto principal |
---|---|---|---|
VERTEX PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | Director/Board Member | |
AFFYMETRIX, INC. | Medical Specialties | Corporate Officer/Principal | |
VERNALIS | Pharmaceuticals: Major | Chief Executive Officer | |
MERCK KGAA | Pharmaceuticals: Major | Corporate Officer/Principal | |
SAREUM HOLDINGS PLC | Miscellaneous | Chairman Director/Board Member | |
GALAPAGOS NV | Biotechnology | Director/Board Member | |
MEDIGENE AG | Biotechnology | Corporate Officer/Principal | |
JPMorgan Securities Plc
JPMorgan Securities Plc Financial ConglomeratesFinance JPMorgan Securities Plc is a brokerage firm headquartered in London, UK. The firm was founded in 1992 and is a wholly-owned subsidiary of JP Morgan Capital Holdings Ltd., ultimately owned by JPMorgan Chase & Co. (NYSE: JPM) in the US. JPMorgan Securities provides market research, proprietary pricing data and analytics, and trade execution across multiple asset classes such as credit, equities and FX. They help institutional investors, traditional and alternative asset and fund managers, broker dealers and equity issuers meet the demands of changing markets. | Financial Conglomerates | Analyst-Equity | |
FEEDBACK PLC | Packaged Software | Chairman Director/Board Member | |
University of Oxford | College/University | Doctorate Degree Doctorate Degree | |
PA Consulting Group Ltd.
PA Consulting Group Ltd. Miscellaneous Commercial ServicesCommercial Services PA Consulting Group Ltd. engages in the provision of management, systems, technology consulting, and innovation services. The company was founded by Ernest Button on September 3, 2015 and is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Corporate Officer/Principal Director/Board Member | |
Bryan, Garnier & Co Ltd.
Bryan, Garnier & Co Ltd. Investment Banks/BrokersFinance Bryan, Garnier & Co Ltd. is a European, full-service growth-focused independent investment bank for technology, healthcare, consumer, and business services companies. The private company is based in London, UK, and has a global presence of subsidiaries in several regions. The British company is well-positioned in a capex intensive industry that is increasingly dynamic both in capital raising and M & A, driven by the 4th Industrial Revolution. Bryan Garnier is the world's leading independent full-service investment bank for European healthcare and technology-led companies and their investors. The company is focused on new disruptive technologies and alternative production models in a variety of domains geared towards fighting climate change and environmental degradation. The consumer sector is transformed across its segments by the way digital natives relate to brands, products, and the environment. The company was founded in 1996 by Olivier Marie Paul Garnier de Falletans. | Investment Banks/Brokers | Analyst-Equity | |
Lonza Biologics Plc
Lonza Biologics Plc Miscellaneous Commercial ServicesCommercial Services Lonza Biologics Plc manufactures monoclonal antibodies, recombinant proteins and diagnostic monoclonal antibodies. The company was founded in 1897 and is headquartered in Slough, the United Kingdom. | Miscellaneous Commercial Services | Chief Executive Officer | |
EOS Biotechnology, Inc.
EOS Biotechnology, Inc. Pharmaceuticals: MajorHealth Technology EOS Biotechnology, Inc. develops therapeutic and diagnostic drugs. The company was founded by Herbert L. Heyneker, John Lowe, David H. Mack, David W. Martin, Richard Murray, and Stephen W. Weiss and is headquartered in Fermont, California. | Pharmaceuticals: Major | Founder | |
ALLERGY THERAPEUTICS PLC | Pharmaceuticals: Other | Director/Board Member | |
Dr. Reddy's Research & Development BV
Dr. Reddy's Research & Development BV Pharmaceuticals: MajorHealth Technology Dr. Reddy's Research & Development BV is engaged in the development and manufacture of injectable pharmaceutical products. It provides formulation, development, drug delivery, and clinical material manufacturing services to biotech and pharmaceutical companies worldwide. The company was founded by Joost J. M. Holthuis on July 20, 1995 and is headquartered in Leiden, Netherlands. | Pharmaceuticals: Major | Chief Executive Officer | |
Howard Hughes Medical Institute, Inc.
Howard Hughes Medical Institute, Inc. Investment Trusts/Mutual FundsMiscellaneous Howard Hughes Medical Institute, Inc. engages in the provision of biomedical research services and science education programs. It funds grants to both institutions and individuals in support of a wide range of science and research-related initiatives, including precollege and undergraduate science education, pre- and post-doctoral research fellowships, and international research activities. The company was founded by Howard R. Hughes in 1953 and is headquartered in Chevy Chase, MD. | Investment Trusts/Mutual Funds | Chief Tech/Sci/R&D Officer | |
Atugen AG
Atugen AG Pharmaceuticals: MajorHealth Technology Atugen AG is a biopharmaceutical company. It develops RNAi therapeutics which focus on vivo applications in oncology and liver diseases, exploiting its proprietary oligonucleotide delivery technologies and chemically stabilized siRNA structures. Founded in 1998, the company is headquartered in Berlin, Germany | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
University of Sussex | College/University | Undergraduate Degree | |
Freie Universität Berlin | College/University | Doctorate Degree | |
Max-Planck-Institute for Molecular Genetics | College/University | Chief Tech/Sci/R&D Officer | |
Beagle Partners LLP
Beagle Partners LLP Investment ManagersFinance Beagle Partners LLP is an independent alternative investment manager headquartered in Bristol, UK. The firm was founded by David Manuel and Anthony Parker in 2004. Beagle Partners manages funds in Emerging Markets. They are experienced managers of Institutional Funds, Alternative Investment Funds and Managed Accounts tailored to client needs. | Investment Managers | Chief Executive Officer | |
Sareum Ltd.
Sareum Ltd. Drugstore ChainsRetail Trade Sareum Ltd. provides drug discovery services for treatment of cancer. The company develops robust pipeline of novel small molecule cancer drug candidates for partnering with pharmaceutical companies. Sareum is headquartered in Cambridge, UK | Drugstore Chains | Director/Board Member Director/Board Member | |
Astra Pharmaceuticals Ltd.
Astra Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Astra Pharmaceuticals Ltd. manufactures & wholesales pharmaceutical products. The company was established in 1908 and is headquartered in London, GB | Pharmaceuticals: Major | Corporate Officer/Principal | |
Boehringer Ingelheim BV
Boehringer Ingelheim BV Drugstore ChainsRetail Trade An international, innovative, pharmaceutical, family business Boehringer Ingelheim BV is an international, innovative pharmaceutical company that focuses on the development and marketing of new drugs that help improve the health and welfare of humans and animals. The company was established in 1945 and is headquartered in Alkmaar, the Netherlands. | Drugstore Chains | Corporate Officer/Principal | |
ACMP IV LLC | Director/Board Member | ||
Kymab Ltd.
Kymab Ltd. Pharmaceuticals: MajorHealth Technology Kymab Ltd. discovers and develops human monoclonal antibody drugs. It is using mouse embryonic stem cell technology to develop its Kymouse platform that focuses on encompassing the diversity of the B lymphocyte component of the human immune system, and has the potential for expansion of diversity beyond the normal human immune response. Kymab was founded by Allan Bradley in 2009 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Chief Executive Officer | |
Weizmann UK
Weizmann UK Miscellaneous Commercial ServicesCommercial Services Weizmann UK is a non-profit company that operates scientific research institutes. The company is based in London, UK. The British company was founded in 1950. | Miscellaneous Commercial Services | Director/Board Member | |
Cristal Delivery BV
Cristal Delivery BV Pharmaceuticals: MajorHealth Technology Cristal Delivery BV develops and manufactures nanomedicines for therapeutic drug optimization. It offers pipeline, oncology, and inflammation programs. The company was founded by Joost J. M. Holthuis and Cristianne Rijcken in April 2011 and is headquartered in Maastricht, the Netherlands. | Pharmaceuticals: Major | Director/Board Member Chairman | |
PMV PHARMACEUTICALS, INC. | Miscellaneous Commercial Services | Founder | |
Mediar Therapeutics, Inc.
Mediar Therapeutics, Inc. BiotechnologyHealth Technology Mediar Therapeutics, Inc. develops therapeutics to halt, reverse and fibrosis. The company was founded by Paul Yaworsky in 2018 and is headquartered in Cambridge, MA. | Biotechnology | Chairman | |
Kymab Group Ltd.
Kymab Group Ltd. Pharmaceuticals: MajorHealth Technology Part of Sanofi, Kymab Group Ltd. is a British biopharmaceutical company that develops human monoclonal antibody drugs. The company is based in Cambridge, UK. The company was founded in 2016 by Alan Bradley. Kymab Group was acquired by Sanofi Foreign Participations BV on April 09, 2021 for $1,970.99 million. | Pharmaceuticals: Major | Chief Executive Officer | |
Pantherna Therapeutics GmbH
Pantherna Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Pantherna Therapeutics GmbH enages in developing of therapeutics for vascular diseases. The company is headquartered in Hennigsdorf, Germany. | Pharmaceuticals: Major | Chief Executive Officer | |
Merck Healthcare | Chief Operating Officer | ||
Moonlake Immunotherapeutics AG
Moonlake Immunotherapeutics AG Pharmaceuticals: MajorHealth Technology Part of MoonLake Immunotherapeutics, Moonlake Immunotherapeutics AG is a Swiss clinical-stage biopharmaceutical company. The company is based in Zug, Switzerland. The company was founded in 2021 by Arnout Ploos van Amstel, Jorge Santos da Silva, Kristian Reich. Moonlake Immunotherapeutics was acquired by Helix Acquisition Corp. on April 05, 2022 for $395.41 million. | Pharmaceuticals: Major | Chairman | |
Bristol Bluegreen Ltd.
Bristol Bluegreen Ltd. Electronic Production EquipmentElectronic Technology Bristol Bluegreen Ltd. is a private company that specializes in voltage management technology. Established in 2013, Bristol Bluegreen aims to become the world's leading provider of voltage management solutions. The company is based in Bristol, UK. The British company's products, such as the BG2 Power Saver, reduce the amount of electricity used by appliances and lighting while ensuring they continue to function properly. The company offers both domestic and commercial products. | Electronic Production Equipment | Director/Board Member | |
MOONLAKE IMMUNOTHERAPEUTICS | Pharmaceuticals: Major | Chairman | |
Cbderma Technology Ltd. | Director/Board Member | ||
Inverpharma Ltd. | Director/Board Member | ||
Las Lilas Ltd. | Director/Board Member | ||
Rosemont Wildwall Ltd. | Director/Board Member |
Estadísticas
Internacional
Reino Unido | 26 |
Estados Unidos | 13 |
Alemania | 8 |
Países Bajos | 4 |
Suiza | 3 |
Sectorial
Health Technology | 27 |
Finance | 5 |
Consumer Services | 5 |
Commercial Services | 5 |
Miscellaneous | 3 |
Operativa
Director/Board Member | 100 |
Chairman | 33 |
Chief Executive Officer | 25 |
Corporate Officer/Principal | 21 |
Independent Dir/Board Member | 16 |
Las relaciones más conectadas
Insiders | |
---|---|
Stephen Parker | 34 |
Stuart J. M. Collinson | 25 |
Alastair Riddell | 24 |
Simon Sturge | 20 |
David Mack | 19 |
Lucio Iannone | 17 |
Jeremy Randall | 10 |
Alistair Gray | 8 |
Anthony Parker | 8 |
Klaus Giese | 7 |
Gareth Hoskin | 7 |
Anthony David Sedgwick | 6 |
Oliver von Stein | 5 |
Jia Huey Cheng | 4 |
Annie Cheng | 4 |
- Bolsa de valores
- Insiders
- Michael Khan
- Conexiones Empresas